| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.6 |